China Digest: Medbanks nabs $59m Series D; Shenzhen Lihexing snags $19m

Medisix
T-lymphocytes attack a migrating cancer cell. Visual from Medisix's website.

China’s oncology database firm Medbanks Network Technology has raised $59 million in a Series D round while Shenzhen Lihexing has secured a funding of nearly $19 million.

Medbanks completes $59m Series D

Medbanks Network Technology, an oncology database firm, has secured 400 million yuan ($59 million) in a Series D financing round led by CDH Investments and CLP Fund, China Money Network reported.

Other investors in this round include IDG Capital and existing investors Tencent, Eight Roads Ventures China and its sister fund F-Prime Capital Partners. Established in 2014, Medbanks has developed a multi-data service platform for oncologists and cancer centers in China. The fresh proceeds will be used to expand its clinical network and improve its database system.

Shenzhen Lihexing snaps $19m funding

Shenzhen Lihexing, a Chinese supplier of industrial automation equipment, has raised 128 million yuan ($18.86 million) in the latest financing round led by Shenzhen Capital Fortune Investment Management.

The round saw participation from Chinese investment house Cowin Capital, CMN reported.

Shenzhen Lihexing manufactures flexible industrial automation equipment such as smart phone testing equipment and automated packaging equipment. It has served over 470 companies including Huawei, Foxconn, Nokia, Microsoft, Canon and Fuji.

Also read:

China Digest: BitRock snags $4m; ABC Tech raises Series B; Ant arm backs campus platform

China Digest: Qualcomm Ventures backs Baicells; CDH leads Series A+ Round in iSpace